Anasarca, a complication of chemotherapy with gemcitabine in two patients with pancreatic cancer
Abstract Pancreatic adenocarcinoma is the fifth most common cause of cancer-related mortality in the world. The nucleoside analogue gemcitabine is the established standard therapy for
